Go Pro

KP Tissue (KPT) Competitors

KP Tissue logo
C$12.73 +0.01 (+0.08%)
As of 03:53 PM Eastern

KPT vs. MAV, CL, CSW.A, HLF, and ADW.A

Should you buy KP Tissue stock or one of its competitors? KP Tissue's main competitors and comparable companies include MAV Beauty Brands (MAV), Colgate-Palmolive (CL), Corby Spirit and Wine (CSW.A), High Liner Foods (HLF), and Andrew Peller (ADW.A). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "consumer staples" sector.

How does KP Tissue compare to MAV Beauty Brands?

MAV Beauty Brands (TSE:MAV) and KP Tissue (TSE:KPT) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

KP Tissue has a consensus target price of C$12.13, suggesting a potential downside of 4.75%. Given MAV Beauty Brands' higher possible upside, equities research analysts clearly believe MAV Beauty Brands is more favorable than KP Tissue.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MAV Beauty Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
KP Tissue
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, KP Tissue had 2 more articles in the media than MAV Beauty Brands. MarketBeat recorded 2 mentions for KP Tissue and 0 mentions for MAV Beauty Brands. KP Tissue's average media sentiment score of 0.30 beat MAV Beauty Brands' score of 0.00 indicating that KP Tissue is being referred to more favorably in the news media.

Company Overall Sentiment
MAV Beauty Brands Neutral
KP Tissue Neutral

MAV Beauty Brands has a beta of 1.82, suggesting that its share price is 82% more volatile than the broader market. Comparatively, KP Tissue has a beta of 0.531195, suggesting that its share price is 47% less volatile than the broader market.

KP Tissue has a net margin of 0.00% compared to MAV Beauty Brands' net margin of -192.08%. KP Tissue's return on equity of 12.81% beat MAV Beauty Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
MAV Beauty Brands-192.08% -266.78% 1.46%
KP Tissue N/A 12.81%N/A

18.5% of MAV Beauty Brands shares are held by institutional investors. Comparatively, 5.2% of KP Tissue shares are held by institutional investors. 57.0% of MAV Beauty Brands shares are held by company insiders. Comparatively, 0.1% of KP Tissue shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

KP Tissue has lower revenue, but higher earnings than MAV Beauty Brands. MAV Beauty Brands is trading at a lower price-to-earnings ratio than KP Tissue, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MAV Beauty BrandsC$84.11M0.00-C$161.56M-C$5.88N/A
KP TissueN/AN/AC$6.38MC$0.8814.47

Summary

KP Tissue beats MAV Beauty Brands on 8 of the 14 factors compared between the two stocks.

How does KP Tissue compare to Colgate-Palmolive?

KP Tissue (TSE:KPT) and Colgate-Palmolive (TSE:CL) are both consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

In the previous week, KP Tissue had 2 more articles in the media than Colgate-Palmolive. MarketBeat recorded 2 mentions for KP Tissue and 0 mentions for Colgate-Palmolive. KP Tissue's average media sentiment score of 0.30 beat Colgate-Palmolive's score of 0.00 indicating that KP Tissue is being referred to more favorably in the media.

Company Overall Sentiment
KP Tissue Neutral
Colgate-Palmolive Neutral

KP Tissue presently has a consensus price target of C$12.13, indicating a potential downside of 4.75%. Given Colgate-Palmolive's higher possible upside, analysts plainly believe Colgate-Palmolive is more favorable than KP Tissue.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KP Tissue
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Colgate-Palmolive
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KP TissueN/AN/AC$6.38MC$0.8814.47
Colgate-PalmoliveN/AN/AN/AN/AN/A

5.2% of KP Tissue shares are owned by institutional investors. 0.1% of KP Tissue shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

KP Tissue's return on equity of 12.81% beat Colgate-Palmolive's return on equity.

Company Net Margins Return on Equity Return on Assets
KP TissueN/A 12.81% N/A
Colgate-Palmolive N/A N/A N/A

Summary

KP Tissue beats Colgate-Palmolive on 6 of the 7 factors compared between the two stocks.

How does KP Tissue compare to Corby Spirit and Wine?

KP Tissue (TSE:KPT) and Corby Spirit and Wine (TSE:CSW.A) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

5.2% of KP Tissue shares are owned by institutional investors. Comparatively, 7.7% of Corby Spirit and Wine shares are owned by institutional investors. 0.1% of KP Tissue shares are owned by company insiders. Comparatively, 52.0% of Corby Spirit and Wine shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Corby Spirit and Wine has a net margin of 10.41% compared to KP Tissue's net margin of 0.00%. Corby Spirit and Wine's return on equity of 13.22% beat KP Tissue's return on equity.

Company Net Margins Return on Equity Return on Assets
KP TissueN/A 12.81% N/A
Corby Spirit and Wine 10.41%13.22%6.49%

KP Tissue has a beta of 0.531195, indicating that its stock price is 47% less volatile than the broader market. Comparatively, Corby Spirit and Wine has a beta of 0.158421, indicating that its stock price is 84% less volatile than the broader market.

In the previous week, KP Tissue and KP Tissue both had 2 articles in the media. Corby Spirit and Wine's average media sentiment score of 0.48 beat KP Tissue's score of 0.30 indicating that Corby Spirit and Wine is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KP Tissue
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Corby Spirit and Wine
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

KP Tissue pays an annual dividend of C$0.75 per share and has a dividend yield of 5.9%. Corby Spirit and Wine pays an annual dividend of C$0.94 per share and has a dividend yield of 6.0%. KP Tissue pays out 85.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Corby Spirit and Wine pays out 80.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Corby Spirit and Wine is clearly the better dividend stock, given its higher yield and lower payout ratio.

KP Tissue currently has a consensus price target of C$12.13, suggesting a potential downside of 4.75%. Corby Spirit and Wine has a consensus price target of C$22.00, suggesting a potential upside of 41.12%. Given Corby Spirit and Wine's stronger consensus rating and higher possible upside, analysts plainly believe Corby Spirit and Wine is more favorable than KP Tissue.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KP Tissue
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Corby Spirit and Wine
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Corby Spirit and Wine has higher revenue and earnings than KP Tissue. Corby Spirit and Wine is trading at a lower price-to-earnings ratio than KP Tissue, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KP TissueN/AN/AC$6.38MC$0.8814.47
Corby Spirit and WineC$271.65M1.63C$23.91MC$1.1713.32

Summary

Corby Spirit and Wine beats KP Tissue on 14 of the 16 factors compared between the two stocks.

How does KP Tissue compare to High Liner Foods?

KP Tissue (TSE:KPT) and High Liner Foods (TSE:HLF) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

KP Tissue pays an annual dividend of C$0.75 per share and has a dividend yield of 5.9%. High Liner Foods pays an annual dividend of C$0.50 per share and has a dividend yield of 3.5%. KP Tissue pays out 85.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. High Liner Foods pays out 57.2% of its earnings in the form of a dividend.

High Liner Foods has higher revenue and earnings than KP Tissue. KP Tissue is trading at a lower price-to-earnings ratio than High Liner Foods, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KP TissueN/AN/AC$6.38MC$0.8814.47
High Liner FoodsC$1.12B0.36C$41.70MC$0.8816.49

High Liner Foods has a net margin of 2.31% compared to KP Tissue's net margin of 0.00%. KP Tissue's return on equity of 12.81% beat High Liner Foods' return on equity.

Company Net Margins Return on Equity Return on Assets
KP TissueN/A 12.81% N/A
High Liner Foods 2.31%6.27%5.30%

5.2% of KP Tissue shares are held by institutional investors. Comparatively, 7.6% of High Liner Foods shares are held by institutional investors. 0.1% of KP Tissue shares are held by insiders. Comparatively, 44.3% of High Liner Foods shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, KP Tissue and KP Tissue both had 2 articles in the media. High Liner Foods' average media sentiment score of 0.87 beat KP Tissue's score of 0.30 indicating that High Liner Foods is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KP Tissue
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
High Liner Foods
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

KP Tissue has a beta of 0.531195, meaning that its stock price is 47% less volatile than the broader market. Comparatively, High Liner Foods has a beta of 0.719861, meaning that its stock price is 28% less volatile than the broader market.

KP Tissue presently has a consensus price target of C$12.13, indicating a potential downside of 4.75%. High Liner Foods has a consensus price target of C$16.70, indicating a potential upside of 15.09%. Given High Liner Foods' stronger consensus rating and higher probable upside, analysts plainly believe High Liner Foods is more favorable than KP Tissue.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KP Tissue
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
High Liner Foods
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

High Liner Foods beats KP Tissue on 13 of the 15 factors compared between the two stocks.

How does KP Tissue compare to Andrew Peller?

KP Tissue (TSE:KPT) and Andrew Peller (TSE:ADW.A) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

KP Tissue has a beta of 0.531195, meaning that its share price is 47% less volatile than the broader market. Comparatively, Andrew Peller has a beta of 0.529368, meaning that its share price is 47% less volatile than the broader market.

In the previous week, KP Tissue had 2 more articles in the media than Andrew Peller. MarketBeat recorded 2 mentions for KP Tissue and 0 mentions for Andrew Peller. KP Tissue's average media sentiment score of 0.30 beat Andrew Peller's score of 0.00 indicating that KP Tissue is being referred to more favorably in the media.

Company Overall Sentiment
KP Tissue Neutral
Andrew Peller Neutral

KP Tissue pays an annual dividend of C$0.75 per share and has a dividend yield of 5.9%. Andrew Peller pays an annual dividend of C$0.25 per share and has a dividend yield of 3.1%. KP Tissue pays out 85.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Andrew Peller pays out 41.7% of its earnings in the form of a dividend.

KP Tissue currently has a consensus price target of C$12.13, suggesting a potential downside of 4.75%. Given KP Tissue's higher probable upside, equities analysts clearly believe KP Tissue is more favorable than Andrew Peller.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KP Tissue
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Andrew Peller
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

5.2% of KP Tissue shares are owned by institutional investors. Comparatively, 1.7% of Andrew Peller shares are owned by institutional investors. 0.1% of KP Tissue shares are owned by insiders. Comparatively, 19.4% of Andrew Peller shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

KP Tissue has a net margin of 0.00% compared to Andrew Peller's net margin of -0.60%. KP Tissue's return on equity of 12.81% beat Andrew Peller's return on equity.

Company Net Margins Return on Equity Return on Assets
KP TissueN/A 12.81% N/A
Andrew Peller -0.60%-0.94%2.01%

KP Tissue has higher earnings, but lower revenue than Andrew Peller. Andrew Peller is trading at a lower price-to-earnings ratio than KP Tissue, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KP TissueN/AN/AC$6.38MC$0.8814.47
Andrew PellerC$389.15M0.91-C$2.30MC$0.5913.56

Summary

KP Tissue beats Andrew Peller on 11 of the 15 factors compared between the two stocks.

Get KP Tissue News Delivered to You Automatically

Sign up to receive the latest news and ratings for KPT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KPT vs. The Competition

MetricKP TissueHousehold Products IndustryConsumer Staples SectorTSE Exchange
Market CapC$127.71MC$10.20BC$15.89BC$12.53B
Dividend Yield6.60%2.75%3.21%6.25%
P/E Ratio14.4713.8513.5439.47
Price / SalesN/A4,480,853.00262,948.859.83
Price / CashN/A15.0357.2582.29
Price / Book1.7910.214.594.71
Net IncomeC$6.38MC$552.50MC$836.00MC$299.09M
7 Day Performance0.08%-0.91%-0.77%-1.21%
1 Month Performance-1.62%1.43%-0.22%4.89%
1 Year Performance35.43%4.71%12.44%28.63%

KP Tissue Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KPT
KP Tissue
1.0353 of 5 stars
C$12.73
+0.1%
C$12.13
-4.8%
+33.2%C$127.71MN/A14.47N/A
MAV
MAV Beauty Brands
N/AN/AN/AN/AC$1.48MC$84.11MN/A73
CL
Colgate-Palmolive
N/AN/AN/AN/AC$0.00N/AN/A33,800
CSW.A
Corby Spirit and Wine
3.1724 of 5 stars
C$15.87
+2.3%
C$22.00
+38.6%
+7.3%C$451.80MC$272.58M13.68175
HLF
High Liner Foods
2.0558 of 5 stars
C$15.16
-0.6%
C$16.70
+10.2%
-8.9%C$424.56MC$1.12B17.23N/A

Related Companies and Tools


This page (TSE:KPT) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners